NCT00851084 - Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

268

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

January 31, 2012

Conditions

Colorectal NeoplasmsNeoplasm Metastasis

Interventions

DRUG

aflibercept

administration: IV infusion

DRUG

oxaliplatin

administration: IV infusion

DRUG

5-FU

administration: IV infusion

DRUG

Folinic Acid

administration: IV infusion

Trial Locations (37)

2310

Sanofi-Aventis Investigational Site Number 036001, Hunter Region Mail Centre

Sanofi-Aventis Investigational Site Number 036003, Hunter Region Mail Centre

4814

Sanofi-Aventis Investigational Site Number 036004, Douglas

10126

Sanofi-Aventis Investigational Site Number 380004, Torino

13353

Sanofi-Aventis Investigational Site Number 276003, Berlin

15706

Sanofi-Aventis Investigational Site Number 724007, Santiago de Compostela

20121

Sanofi-Aventis Investigational Site Number 380002, Milan

28007

Sanofi-Aventis Investigational Site Number 724004, Madrid

28040

Sanofi-Aventis Investigational Site Number 724001, Madrid

30625

Sanofi-Aventis Investigational Site Number 276001, Hanover

45659

Sanofi-Aventis Investigational Site Number 276005, Recklinghausen

46009

Sanofi-Aventis Investigational Site Number 724003, Valencia

48149

Sanofi-Aventis Investigational Site Number 276002, Münster

50141

Sanofi-Aventis Investigational Site Number 380001, Florence

66421

Sanofi-Aventis Investigational Site Number 276006, Homberg (Efze)

68167

Sanofi-Aventis Investigational Site Number 276004, Mannheim

70126

Sanofi-Aventis Investigational Site Number 380005, Bari

98039

Sanofi-Aventis Investigational Site Number 380003, Taormina

197758

Sanofi-Aventis Investigational Site Number 643005, Saint Petersburg

354057

Sanofi-Aventis Investigational Site Number 643001, Sochi

357500

Sanofi-Aventis Investigational Site Number 643002, Pyatigorsk

01307

Sanofi-Aventis Investigational Site Number 276007, Dresden

614-735

Sanofi-Aventis Investigational Site Number 410003, Busan

361-711

Sanofi-Aventis Investigational Site Number 410004, Cheongju-si

700-721

Sanofi-Aventis Investigational Site Number 410005, Daegu

Unknown

Sanofi-Aventis Investigational Site Number 410002, Daejeon

410-769

Sanofi-Aventis Investigational Site Number 410007, Goyang-Si, Gyeonggi-Do

120-752

Sanofi-Aventis Investigational Site Number 410006, Seoul

152-703

Sanofi-Aventis Investigational Site Number 410001, Seoul

682-714

Sanofi-Aventis Investigational Site Number 410008, Ulsan

08036

Sanofi-Aventis Investigational Site Number 724005, Barcelona

08208

Sanofi-Aventis Investigational Site Number 724002, Sabadell

LS9 7TF

Sanofi-Aventis Investigational Site Number 826004, Leeds

LE1 5WW

Sanofi-Aventis Investigational Site Number 826001, Leicester

M20 4BX

Sanofi-Aventis Investigational Site Number 826002, Manchester

SL2 4HL

Sanofi-Aventis Investigational Site Number 826003, Slough

SO16 6YD

Sanofi-Aventis Investigational Site Number 826005, Southampton